PatientsVille.com LogoPatientsVille.com

Community Acquired Pneumonia | Bacterial Pneumonia Score (BPS) Guided Antibiotic Use in Children With Pneumonia and Pneumococcal Vaccine

Community Acquired Pneumonia research study

What is the primary objective of this study?

The aim of this study is to test if BPS (Bacterial Pneumonia Score) guided antibiotic use in children with non severe community acquired pneumonia (CAP) and pneumoccocal vaccine will reduce antibiotic use as compared to standard care practice (current guidelines for CAP).

Who is eligible to participate?

Inclusion Criteria: - Children aged 3-60 months assisted as outpatients for non severe community acquired pneumonia and pneumoccocal vaccine and complete immunisation with pneumoccocal vaccine. Exclusion Criteria: - Wheezing - Severe pneumonia - Pulmonary or cardiovascular chronic disease - Antibiotic use in the previous two weeks - Hospitalization for any reason in the previous two weeks

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Community Acquired Pneumonia

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Behavioral:BPSIn this study a strategy based on BPS guided antibiotic use in children with community acquired pneumonia implementation will be compared with enforced guideline.

Behavioral:GuidelineStrategy based on enforced guideline guided antibiotic use

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

BPS (Bacterial Pneumonia Score)Strategy based on BPS guided antibiotic use

GuidelineStrategy based on enforced guideline guided antibiotic use

Study Status

Completed

Start Date: July 2013

Completed Date: July 2014

Phase: N/A

Type: Interventional

Design:

Primary Outcome: Use of Antibiotics in Each Group

Secondary Outcome: Treatment Failure in Each Group

Study sponsors, principal investigator, and references

Principal Investigator: Fernando A Torres, MD, PhD

Lead Sponsor: Hospital General de NiƱos Pedro de Elizalde

Collaborator:

More information:https://clinicaltrials.gov/show/NCT01875731

Moreno L, Krishnan JA, Duran P, Ferrero F. Development and validation of a clinical prediction rule to distinguish bacterial from viral pneumonia in children. Pediatr Pulmonol. 2006 Apr;41(4):331-7. Erratum in: Pediatr Pulmonol. 2006 May;41(5):494.

Discuss Pneumonia